CBSET, a preclinical research company, announced that it has appointed Michael Naimark as director of business development.
Most recently, Mr. Naimark was employed by the Neural Stem Cell Institute (NSCI) as project manager overseeing the development of a cell-based therapy for macular degeneration under a 4-year award from the New York Stem Cell Foundation.

Previously, Mr. Naimark was co-owner of Care Research, a preclinical research organization where he provided operational, sales, and marketing oversight as Director of Surgical Models.

Prior to founding Care Research, Mr. Naimark helped launch Preclinical Research Services Inc., a preclinical research organization, and served as senior study director for several years. ■

• Chiasma re-appoints Roni Mamluk to board
• BayCoast Bank appoints James Wallace as CFO
• Pulmatrix appoints Amit D. Munshi to board
• Syros Pharmaceuticals appoints Srinivas Akkaraju to board
• Merrimack Pharma names Sergio Santillana as CMO

---

More inside POST